Retatrutide, a experimental dual activator of the GLP-1 binding site and glucose-dependent secreted polypeptide (GIP) receptor , is exhibiting promising results in initial human studies. Ongoing https://keybookmarks.com/story21393370/retatrutide-emerging-research-and-potential-therapeutic-roles